Plus, news about ANI, Genentech, Telix and Madrigal:
Arrowhead’s partnership with Sarepta Therapeutics is business as usual: Amid the blistering pace of updates from Sarepta over the past week, Arrowhead Pharmaceuticals sought to get ahead ...
↧